Kim, D. W. External Author

Publications

Sort by

Selected publications

  • BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phaseLeukemia2015 Academic Article GET IT
    Times cited: 18